SG&A Expenses

$561.20M

Quarterly · Period ending: Jun 30, 2026 · USD

EW SG&A Expenses

Latest reported$561.20Mperiod endingJun 30, 2026

EW Quarterly SG&A Expenses ($69.00M → $561.20M)

Quarterly SG&A Expenses

High-resolution chart · PNG

EW sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences SG&A Expenses — Quarterly (USD)
Period ending	SG&A Expenses (USD)
Jun 30, 2026	561,200,000
Mar 31, 2026	522,200,000
Dec 31, 2025	602,900,000
Sep 30, 2025	514,600,000
Jun 30, 2025	502,000,000
Mar 31, 2025	465,700,000
Dec 31, 2024	491,900,000
Sep 30, 2024	421,400,000
Jun 30, 2024	450,800,000
Mar 31, 2024	428,400,000
Dec 31, 2023	416,600,000
Sep 30, 2023	381,900,000
Jun 30, 2023	410,400,000
Mar 31, 2023	436,300,000
Dec 31, 2022	411,000,000
Sep 30, 2022	377,300,000
Jun 30, 2022	409,000,000
Mar 31, 2022	370,300,000
Dec 31, 2021	424,000,000
Sep 30, 2021	364,100,000
Jun 30, 2021	374,100,000
Mar 31, 2021	330,900,000
Dec 31, 2020	338,700,000
Sep 30, 2020	307,500,000
Jun 30, 2020	275,800,000
Mar 31, 2020	308,600,000
Dec 31, 2019	347,700,000
Sep 30, 2019	306,800,000
Jun 30, 2019	309,000,000
Mar 31, 2019	280,600,000
Dec 31, 2018	288,300,000
Sep 30, 2018	269,100,000
Jun 30, 2018	273,900,000
Mar 31, 2018	254,900,000
Dec 31, 2017	265,399,999
Sep 30, 2017	244,200,000
Jun 30, 2017	243,700,000
Mar 31, 2017	229,100,000
Dec 31, 2016	233,600,000
Sep 30, 2016	229,500,000
Jun 30, 2016	228,800,000
Mar 31, 2016	212,700,000
Dec 31, 2015	222,300,000
Sep 30, 2015	212,000,000
Jun 30, 2015	213,900,000
Mar 31, 2015	202,500,000
Dec 31, 2014	223,100,000
Sep 30, 2014	222,200,000
Jun 30, 2014	215,500,000
Mar 31, 2014	197,200,000
Dec 31, 2013	190,500,000
Sep 30, 2013	180,500,000
Jun 30, 2013	189,400,000
Mar 31, 2013	185,200,000
Dec 31, 2012	177,900,000
Sep 30, 2012	167,800,000
Jun 30, 2012	182,400,000
Mar 31, 2012	177,200,000
Dec 31, 2011	163,400,000
Sep 30, 2011	165,500,000
Jun 30, 2011	163,200,000
Mar 31, 2011	150,300,000
Dec 31, 2010	142,400,000
Sep 30, 2010	133,000,000
Jun 30, 2010	140,600,000
Mar 31, 2010	134,000,000
Dec 31, 2009	132,300,000
Sep 30, 2009	126,100,000
Jun 30, 2009	128,500,000
Mar 31, 2009	121,900,000
Dec 31, 2008	120,200,000
Sep 30, 2008	119,300,000
Jun 30, 2008	126,500,000
Mar 31, 2008	114,600,000
Dec 31, 2007	114,500,000
Sep 30, 2007	103,200,000
Jun 30, 2007	101,700,000
Mar 31, 2007	98,600,000
Dec 31, 2006	95,100,000
Sep 30, 2006	91,700,000
Jun 30, 2006	97,000,000
Mar 31, 2006	92,000,000
Dec 31, 2005	87,100,000
Sep 30, 2005	85,900,000
Jun 30, 2005	90,100,000
Mar 31, 2005	85,600,000
Dec 31, 2004	82,700,000
Sep 30, 2004	79,700,000
Jun 30, 2004	81,000,000
Mar 31, 2004	76,500,000
Dec 31, 2003	72,200,000
Sep 30, 2003	70,500,000
Jun 30, 2003	75,800,000
Mar 31, 2003	71,400,000
Dec 31, 2002	68,700,000
Sep 30, 2002	54,200,000
Jun 30, 2002	54,300,000
Mar 31, 2002	50,700,000
Dec 31, 2001	50,100,000
Sep 30, 2001	46,400,000